The Importance of Other HPV in High-Grade CIN

Farzaneh, Farah; Ghaffari, Elnaz; Hosseini, Maryam Sadat; Ashraf Ghanjouee, Tahereh; Hosseini, Afsaneh

doi:10.30699/jogcr.8.6.571

Document Type : Original Research Article

Authors

¹ Preventative Gynecology Research Center, Shahid Behesti University of Medical Sciences, Tehran, Iran

² Spaceborn United Company, Eindhoven, Netherlands, Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

https://doi.org/10.30699/jogcr.8.6.571

Abstract

Background & Objective: High-risk (HR) HPV infection is the major cause of cervical cancer, which is still one of the most common cancers among women. Based on some not-published results, it seems that some of the other HR HPVs might be as important as HPV 16, and 18 in developing high-grade CIN. This study was conducted to determine the relationship between Other HPV and high-grade CIN.
Materials & Methods: In this prospective study from 2019 to 2022 (approved by the ethics committee), all women with positive HPV based on the COBAS method were invited to participate in the study (N=646). For all the patients, colposcopy was done, and then the liquid-based samples of women with Other HPV positives were reanalyzed by HPV typing.
Results: All the patients who were infected with HPV18 were involved in CIN1. On the other hand, 50% of patients who were infected with HPV18 were involved in CIN2. 50% of patients with HPV45 were involved in CIN2. There is also a significant relationship between HPV31 and CIN3.
Conclusion: Because in our study there was a significant relationship between CIN3 and HPV31; and CIN2 with HPV45, and in the COBAS method, HPV31 and HPV45 are only reported under the general title of Other HPV, because of the possibility of the importance of other HPV with high-grade neoplasias, it is recommended to analyze the other HPV with HPV typing. Further studies are needed to confirm our findings.

Highlights

✅ Because in our study there was a significant relationship between CIN3 and HPV31; and CIN2 with HPV45, and in the COBAS method, HPV31 and HPV45 are only reported under the general title of Other HPV, because of the possibility of the importance of other HPV with high-grade neoplasias, it is recommended to analyze the other HPV with HPV typing. Further studies are needed to confirm our findings.

Keywords

Main Subjects

Gynecology Oncology

References

1. McBride KR, Singh S. Predictors of Adults' Knowledge and Awareness of HPV, HPV-Associated Cancers, and the HPV Vaccine: Implications for Health Education. Health Educ Behav. 2018;45(1):68-76. [DOI:10.1177/1090198117709318] [PMID]

2. Farzaneh F, Mohammadi S, Ghaffari E, Hosseini A, Younesi S, Taheri Amin MM, et al. Frequency of HR-HPV Types in Patients with High Grade Cervical Intraepithelial Neoplasia (CIN). J Obstet Gynecol Cancer Res. 2021;6(3):122-7. [DOI:10.30699/jogcr.6.3.122]

3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. [DOI:10.3322/caac.21660] [PMID]

4. Hildesheim A. Human Papillomavirus Variants: Implications for Natural History Studies and Vaccine Development Efforts. J Natl Cancer Inst. 1997;89(11):752-3. [DOI:10.1093/jnci/89.11.752] [PMID]

5. Burchell AN, Winer RL, de Sanjosé S, Franco EL. Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006;24(3):S3/52-61. [DOI:10.1016/j.vaccine.2006.05.031] [PMID]

6. Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, et al. Global burden of human papillomavirus and related diseases. Vaccine. 2012;30(5):F12-23. [DOI:10.1016/j.vaccine.2012.07.055] [PMID]

7. Aminisani N, Armstrong BK, Canfell K. Cervical cancer screening in Middle Eastern and Asian migrants to Australia: a record linkage study. Cancer Epidemiol. 2012;36(6):e394-400. [DOI:10.1016/j.canep.2012.08.009] [PMID]

8. Bell RJ, Fradkin P, Parathithasan N, Robinson PJ, Schwarz M, Davis SR. Pregnancy-associated breast cancer and pregnancy following treatment for breast cancer, in a cohort of women from Victoria, Australia, with a first diagnosis of invasive breast cancer. Breast. 2013;22(5):980-5. [DOI:10.1016/j.breast.2013.05.013] [PMID]

9. Esmaeili M, Bonyadi M, Dastranj A, Alizadeh M, Melli MS, Shobeiri MJ. HPV typing in women with cervical precancerous and cancerous lesions in northwestern Iran. Gynecol Obstet Invest. 2008;66(1):68-72. [DOI:10.1159/000134917] [PMID]

10. Seifi S, Asvadi Kermani I, Dolatkhah R, Asvadi Kermani A, Sakhinia E, Asgarzadeh M, et al. Prevalence of oral human papilloma virus in healthy individuals in East azerbaijan province of iran. Iran J Public Health. 2013;42(1):79-85.

11. Park KJ, Roma A, Singh N, Gilks CB, Oliva E, Abu-Rustum N, et al. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2021;40(Suppl 1):S92-s101. [DOI:10.1097/PGP.0000000000000758] [PMID] [PMCID]

12. Franco EL, Villa LL, Sobrinho JP, Prado JM, Rousseau MC, Désy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415-23. [DOI:10.1086/315086] [PMID]

13. Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health. 2014;80(5):412-7. [DOI:10.1016/j.aogh.2014.09.014] [PMID]

14. Jamali B, Jamali S. RETRACTED: Relative Frequency of Human papillomavirus Genotypes and its Related Characteristics in Women Referred to Alzahra Hospital in Tabriz (RETRACTED). Iran J Med Microbiol. 2018;12(1):51-60.

15. Khodakarami N, Moradi A, Mirzaei H, Farzaneh F, Yavari P, Akbari ME. Frequency of Human Papillumavirus among Women with High-Grade Squamous Intraepithelial Lesions and Invasive Cervical Cancer Attending Shahid Beheshti University of Medical Sciences Clinics, Tehran, Iran. Iran J Public Health. 2014;43(11):1563-8.

16. Jamdar F, Farzaneh F, Navidpour F, Younesi S, Balvayeh P, Hosseini M, et al. Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing. Infect Agent Cancer. 2018;13:6. [DOI:10.1186/s13027-018-0178-5] [PMID] [PMCID]

17. Hosseini MS, Khosravi D, Farzaneh F, Ebrahimi A, Arab M, Ashraf Ganjoie T, et al. Evaluation of Anal Cytology in Women with History of Abnormal Pap Smear, Cervical Intraepithelial Neoplasia, Cervical Cancer and High Risk HPV for Anogenital Dysplasia. Asian Pac J Cancer Prev. 2018;19(11):3071-5. [DOI:10.31557/APJCP.2018.19.11.3071] [PMID] [PMCID]

18. Hoffman SR, Le T, Lockhart A, Sanusi A, Dal Santo L, Davis M, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review. Int J Cancer. 2017;141(1):8-23. [DOI:10.1002/ijc.30623] [PMID] [PMCID]

19. Mousavi A-S, Akhavan S, Sabzi shahrbabaki F, Izadi-mood N, Yarandi F, Ghazimoghadam M, et al. Assessment of the Diagnostic Value of High-Risk HPV Molecular-based Methods for Triage of Iranian Women with Abnormal Cytological Findings of ASC-US and LSIL. J Obstet Gynecol Cancer Res. 2022;7(3):151-7. [DOI:10.30699/jogcr.7.3.151]

20. Brink AA, Snijders PJ, Meijer CJ. HPV detection methods. Dis Markers. 2007;23(4):273-81. [DOI:10.1155/2007/147429] [PMID] [PMCID]

21. Ylitalo N, Sørensen P, Josefsson AM, Magnusson PK, Andersen PK, Pontén J, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355(9222):2194-8. [DOI:10.1016/S0140-6736(00)02402-8] [PMID]

22. Josefsson AM, Magnusson PK, Ylitalo N, Sørensen P, Qwarforth-Tubbin P, Andersen PK, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet. 2000;355(9222):2189-93. [DOI:10.1016/S0140-6736(00)02401-6] [PMID]

23. van Duin M, Snijders PJ, Schrijnemakers HF, Voorhorst FJ, Rozendaal L, Nobbenhuis MA, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer. 2002;98(4):590-5. [DOI:10.1002/ijc.10232] [PMID]

24. Snijders PJF, Hogewoning CJA, Hesselink AT, Berkhof J, Voorhorst FJ, Bleeker MCG, et al. Determination of viral load thresholds in cervical scrapings to rule out CIN 3 in HPV 16, 18, 31 and 33‐positive women with normal cytology. Int J Cancer Res. 2006;119(5):1102-7. [DOI:10.1002/ijc.21956] [PMID]

25. Akbari Sene A, Farzaneh F, Mehrnami A, Faizei AM, Alizadeh A, Saadat Mostafavi SR, et al. Diagnostic value and agreement of transrectal in comparison with transvaginal sonography among women with abnormal uterine bleeding. J Ultrasound. 2022;25(3):687-97. [DOI:10.1007/s40477-021-00647-y] [PMID] [PMCID]

Journal of Obstetrics, Gynecology and Cancer Research

The Importance of Other HPV in High-Grade CIN

References

References

Volume 8, Issue 6 - Serial Number 35
November and December 2023
Pages 571-578

The Importance of Other HPV in High-Grade CIN

References

References

Volume 8, Issue 6 - Serial Number 35November and December 2023Pages 571-578

Volume 8, Issue 6 - Serial Number 35
November and December 2023
Pages 571-578